LeMaitre Vascular Q1 sales $59.9M (+12% YoY), raises FY guidance, declares $0.20 dividend

LEMAITRE VASCULAR INC

2025-Q1 EPS reported $0.48 revenue$59,871,000

Q1 sales $59.9M, +12% reported (+13% organic); EPS $0.48, +10% YoY.
FY 2025 sales guidance raised to $242-249M (mid $245M, +13% organic) from prior $239M.
Quarterly dividend of $0.20/share declared, payable May 29 to holders of record May 15.
Artegraft received MDR CE Mark on April 29; European launch to begin.
Ended Elutia porcine patch distribution agreement on April 30 (U.S. hospital sales $5.0M in 2024).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.